Articles

arbuthnot

Ango Pacific enjoys record 2017 with royalty income of £37.4 mln

Exelixis’ Partner Ipsen Announces EMA Validation of the Application for a New Indication for CABOMETYX® (cabozantinib) for Previously Treated Advanced Hepatocellular Carcinoma | Business Wire

Kiadis Pharma on track with European regulatory review for ATIR101

GLENMARK PHARMA..CIBLE 580

Produit cart-t

AveXis Gene Therapy Awarded SAKIGAKE Designation for Spinal Muscular Atrophy Type 1

Opthea Doses Patients in Europe and Israel in Phase 2b Study of OPT-302 for Wet AMD

ROCHE

SKINBIO THERAPEUTICS

BAE SYSTEMS